2023 Classic Lectures in Pathology: What You Need to Know: Breast Pathology
- Released
- 01/15/23
- Duration
- 8 Hours
- Price
- $640.00
Cart
Purchase On Demand Above (Recommended)
Purchase on USB
Find a Live CME Meeting in Your Medical Specialty
CME Expiration Date 1/14/2026
|
Ductal Carcinoma In Situ of Breast: Updates and Differential Diagnoses
Charles D. Sturgis, M.D.
|
1.00 Hrs |
$90.00 |
Add to Cart |
|
Molecular Classification of Breast Cancer and Prognostic Testing
Mara H. Rendi, M.D., Ph.D.
|
1.00 Hrs |
$90.00 |
Add to Cart |
|
The Low Grade Breast Neoplasia Pathway
Mara H. Rendi, M.D., Ph.D.
|
0.75 Hrs |
$67.50 |
Add to Cart |
|
Updates on the 8th Edition of the AJCC Staging Manual for Breast Cancer
Mara H. Rendi, M.D., Ph.D.
|
0.75 Hrs |
$67.50 |
Add to Cart |
|
Problematic Issues in Breast Core Biopsies
Stuart J. Schnitt, M.D.
|
0.75 Hrs |
$67.50 |
Add to Cart |
|
Spindle Cell Lesions in the Breast
Mara H. Rendi, M.D., Ph.D.
|
1.00 Hrs |
$90.00 |
Add to Cart |
|
Special Type Breast Cancers
Mara H. Rendi, M.D., Ph.D.
|
0.75 Hrs |
$67.50 |
Add to Cart |
|
Inflammatory and Reactive Lesions of the Breast
Stuart J. Schnitt, M.D.
|
1.00 Hrs |
$90.00 |
Add to Cart |
|
The Challenge of Evaluating Post-Neoadjuvant Systemic Therapy Breast Specimens
Stuart J. Schnitt, M.D.
|
1.00 Hrs |
$90.00 |
Add to Cart |
This CME Activity offers a practical review of breast pathology combining basic to advanced techniques, pearls and pitfalls to pathologic diagnosis and case reviews.
This CME activity is intended and designed to educate pathologists.
Physicians: Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Educational Symposia designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All activity participants are required to complete the credit application in order to be awarded credit. Course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.
AMA PRA Category 1 Credit(s)TM for these programs may be claimed until January 14, 2026.
This program is planned and organized by Educational Symposia, a leader in accredited continuing education since 1975.
This activity was planned and produced in accordance with the ACCME Essential Areas and Elements.
At the completion of this CME teaching activity, you should be able to:
-
Explain the spectrum of benign spindle cell lesions in the breast.
-
Utilize molecular classification of breast cancer.
-
Review the updates to the AJCC staging of breast cancer.
-
Differentiate inflammatory and reactive lesions from other forms of breast pathologies.
-
Discuss breast cancer predictive factor testing (ER, PR & HER2).
-
Describe the diagnostic features and clinical significance of a variety of breast lesions with particular reference to the implications of these diagnoses in core needle biopsy specimens.
No special educational preparation is required for this CME activity.
Associate Professor
University of Washington, Seattle WA
Pathologist
Hospital Pathology Associates
Minneapolis, MN
Chief of Breast Oncologic Pathology, Dana Farber/Brigham and Women's Cancer Center
Associate Director, Dana-Farber Cancer Institute/Brigham and Women's Hospital Breast Oncology Program
Professor of Pathology, Harvard Medical School
Boston, MA
Staff Cytopathologist
R.J. Tomsich Pathology & Lab Medicine Institute
Cleveland Clinic
Associate Professor of Pathology
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland, OH